|
|
Volumn 368, Issue 2, 2013, Pages 188-189
|
|
Prasugrel versus clopidogrel for acute coronary syndromes
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOPIDOGREL;
CYTOCHROME P450 1A2;
PRASUGREL;
ANTITHROMBOCYTIC AGENT;
DRUG DERIVATIVE;
PIPERAZINE DERIVATIVE;
THIOPHENE DERIVATIVE;
TICLOPIDINE;
ACUTE CORONARY SYNDROME;
ALLELE;
ANTICOAGULANT THERAPY;
BLEEDING;
CARDIOVASCULAR RISK;
CORONARY ARTERY DISEASE;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
HEART MUSCLE ISCHEMIA;
HETEROZYGOTE;
HIGH RISK PATIENT;
HUMAN;
LETTER;
LIVER METABOLISM;
LOSS OF FUNCTION MUTATION;
LOW DRUG DOSE;
PERSONALIZED MEDICINE;
PLATELET REACTIVITY;
PRIORITY JOURNAL;
PROTEIN INDUCTION;
RECURRENT DISEASE;
SMOKING;
TREATMENT RESPONSE;
HEART MUSCLE REVASCULARIZATION;
PHARMACOGENOMICS;
POPULATION RESEARCH;
THROMBOCYTE FUNCTION;
FEMALE;
HEART INFARCTION;
MALE;
NOTE;
UNSTABLE ANGINA PECTORIS;
ACUTE CORONARY SYNDROME;
ANGINA, UNSTABLE;
FEMALE;
HUMANS;
MALE;
MYOCARDIAL INFARCTION;
PIPERAZINES;
PLATELET AGGREGATION INHIBITORS;
THIOPHENES;
TICLOPIDINE;
|
|
EID: 84872071749
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1213509 Document Type: Letter |
|
Times cited : (12)
|
|
References (2)
|
